Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:
DENTSPLY SIRONA (NASDAQ:XRAY - Get Rating) was upgraded by investment analysts at StockNews.com from a "hold" rating to a "buy" rating in a research note issued on Sunday.
Several other analysts have also commented on XRAY. UBS Group raised shares of DENTSPLY SIRONA from a "neutral" rating to a "buy" rating and lowered their price objective for the stock from $58.00 to $47.00 in a research report on Wednesday, June 1st. Robert W. Baird lowered shares of DENTSPLY SIRONA from an "outperform" rating to a "neutral" rating and lowered their price objective for the stock from $67.00 to $48.00 in a research report on Tuesday, April 19th. HC Wainwright reduced their target price on shares of DENTSPLY SIRONA from $58.00 to $48.00 and set a "hold" rating for the company in a research note on Friday, April 22nd. Piper Sandler reduced their target price on shares of DENTSPLY SIRONA from $41.00 to $38.00 in a research note on Monday, July 11th. Finally, Barrington Research reduced their target price on shares of DENTSPLY SIRONA from $53.00 to $51.00 in a research note on Wednesday, May 11th. One analyst has rated the stock with a sell rating, five have issued a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Hold" and an average target price of $48.11.DENTSPLY SIRONA Stock Up 2.6 %
Shares of NASDAQ XRAY opened at $36.84 on Friday. The stock has a market capitalization of $7.94 billion, a P/E ratio of 21.80, a P/E/G ratio of 2.89 and a beta of 0.91. The company has a 50-day moving average price of $36.56 and a 200-day moving average price of $43.90. DENTSPLY SIRONA has a 1 year low of $33.78 and a 1 year high of $63.10. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.45 and a quick ratio of 1.03.
DENTSPLY SIRONA (NASDAQ:XRAY - Get Rating) last released its quarterly earnings results on Tuesday, May 10th. The medical instruments supplier reported $0.52 earnings per share for the quarter, beating analysts' consensus estimates of $0.50 by $0.02. DENTSPLY SIRONA had a net margin of 8.81% and a return on equity of 11.63%. The company had revenue of $9.67 billion for the quarter, compared to analyst estimates of $982.05 million. During the same period last year, the firm earned $0.72 earnings per share. The firm's revenue was up 841.1% on a year-over-year basis. On average, equities research analysts forecast that DENTSPLY SIRONA will post 2.41 EPS for the current fiscal year. Institutional Investors Weigh In On DENTSPLY SIRONA
Hedge funds have recently made changes to their positions in the business. SOA Wealth Advisors LLC. lifted its holdings in shares of DENTSPLY SIRONA by 26,666.7% in the 1st quarter. SOA Wealth Advisors LLC. now owns 803 shares of the medical instruments supplier's stock worth $39,000 after acquiring an additional 800 shares during the last quarter. Parkside Financial Bank & Trust lifted its holdings in shares of DENTSPLY SIRONA by 163.7% in the 1st quarter. Parkside Financial Bank & Trust now owns 915 shares of the medical instruments supplier's stock worth $46,000 after acquiring an additional 568 shares during the last quarter. National Bank of Canada FI bought a new stake in shares of DENTSPLY SIRONA in the 4th quarter worth approximately $55,000. Van ECK Associates Corp bought a new stake in DENTSPLY SIRONA during the 2nd quarter valued at $41,000. Finally, Dixon Hughes Goodman Wealth Advisors LLC bought a new stake in DENTSPLY SIRONA during the 1st quarter valued at $79,000. 94.79% of the stock is currently owned by institutional investors. DENTSPLY SIRONA Company Profile (Get Rating)
DENTSPLY SIRONA Inc designs, develops, manufactures, distributes, and sells various dental products and technologies for professional dental market worldwide. It offers dental equipment, including treatment centers, imaging equipment, motorized dental handpieces, and other instruments; imaging equipment; treatment centers comprising basic dentist chairs, sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, and specialist centers; and lab equipment, such as amalgamators, mixing machines, and porcelain furnaces.Read MoreGet a free copy of the StockNews.com research report on DENTSPLY SIRONA (XRAY)MarketBeat: Week in Review 8/1 - 8/5How to Use High Beta Stocks to Maximize Your Investing ProfitsCronos Group Inc's Revenues Are Up, Is It Time to Buy?Why Apple Could Be At All-Time Highs By Year EndBeyond Meat Is Not Beyond Hope, And It's Cheap
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:
Today, Kate’s guest is Rhys Williams, chief investment officer for the Opportunistic All Cap Equity, a long-short strategy at Spouting Rock Asset Management.
Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.
Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.
Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.
MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.
Twitter Facebook StockTwits Financial Juice YouTube
© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved. 326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257 MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds
© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.